Dr. John Reneau, MD,PhD
Claim this profileOhio State University Wexner Medical Center
Studies Lymphoma
Studies Leukemia
4 reported clinical trials
5 drugs studied
Area of expertise
1Lymphoma
TCR positive
Stage II
Stage I
2Leukemia
TCR positive
CD8 positive
NK-cell population positive
Affiliated Hospitals
Clinical Trials John Reneau, MD,PhD is currently running
Oral Azacitidine
for Leukemia
This trial studies the best dose and effects of oral azacitidine in patients with T-cell large granular lymphocytic leukemia that has come back or did not respond to previous treatments. Azacitidine is a chemotherapy drug that stops cancer cells from growing, dividing, or spreading.
Recruiting1 award Phase 1 & 215 criteria
Ruxolitinib
for Large Granular Lymphocytic Leukemia
This trial tests if ruxolitinib can shrink tumors in patients with a specific type of leukemia called T-cell large granular lymphocyte leukemia. Ruxolitinib works by blocking enzymes that cancer cells need to grow. The goal is to see if this medication can help these patients when other treatments might not work. Ruxolitinib is an oral medication used to treat myelofibrosis and polycythemia vera, but its effects in these conditions are uncertain.
Recruiting1 award Phase 2
More about John Reneau, MD,PhD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments John Reneau, MD,PhD has experience with
- Ruxolitinib
- Brentuximab Vedotin
- Lenalidomide
- Oral Azacitidine
- KT-333
Breakdown of trials John Reneau, MD,PhD has run
Lymphoma
Leukemia
Childhood Cancer
Large Granular Lymphocyte Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Reneau, MD,PhD specialize in?
John Reneau, MD,PhD focuses on Lymphoma and Leukemia. In particular, much of their work with Lymphoma has involved TCR positive patients, or patients who are Stage II.
Is John Reneau, MD,PhD currently recruiting for clinical trials?
Yes, John Reneau, MD,PhD is currently recruiting for 2 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that John Reneau, MD,PhD has studied deeply?
Yes, John Reneau, MD,PhD has studied treatments such as Ruxolitinib, Brentuximab Vedotin, Lenalidomide.
What is the best way to schedule an appointment with John Reneau, MD,PhD?
Apply for one of the trials that John Reneau, MD,PhD is conducting.
What is the office address of John Reneau, MD,PhD?
The office of John Reneau, MD,PhD is located at: Ohio State University Wexner Medical Center, Columbus, Ohio 43210-1240 United States. This is the address for their practice at the Ohio State University Wexner Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.